SAM
EDIT icon

Shell Asset Management’s Editas Medicine EDIT Stock Holding History

Shell Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$382K Buy
81,714
+15,830
+24% +$132K 0.02% 568
2023
Q4 		$667K Sell
65,884
-16,246
-20% -$143K 0.03% 419
2023
Q3 		$641K Sell
82,130
-102
-0.1% -$875 0.03% 466
2023
Q2 		$677K Buy
+82,232
New +$716K 0.03% 469

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Shell Asset Management's EDIT Position: Q1 2024 in Review

Shell Asset Management increased its Editas Medicine (EDIT) stake by 24% in Q1 2024, buying an estimated $132K and bringing the position to 81,714 shares worth $382K. The position accounts for 0.02% of the portfolio, ranked #568.

Shell Asset Management first reported a position in EDIT in Q2 2023 and has held it in 4 quarters since. The position peaked at $677K in Q2 2023. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

  • Shell Asset Management held 81,714 shares of Editas Medicine worth $382K as of Q1 2024.
  • Shell Asset Management bought 15,830 Editas Medicine shares in Q1 2024, an estimated $132K.
  • Editas Medicine made up 0.02% of Shell Asset Management's portfolio in Q1 2024, its #568 holding.
  • Shell Asset Management first reported a position in Editas Medicine in Q2 2023 and has held it in 4 quarters since.
  • Shell Asset Management's Editas Medicine position peaked at $677K in Q2 2023.
  • 225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on Shell Asset Management's 13F filing for Q1 2024, filed 14 May 2024.